Glen Sumner
Clinical Associate Professor
Cardiac Electrophysiologist
Cardiologist
BSc. (Honours) Life Sciences
MD
Cardiology and Internal Medicine
MSc. Health Economics, Management and Cardiovascular Outcomes
Contact information
Phone
Research and teaching
Research areas
- Collaborative clinical research as local principal investigator for multi-centre cardiac device
- Arrhythmia clinical trials
- Emerging focus on health policy: physician remuneration strategies and health care financing
Biography
I am Calgary-born and attended high school here. I did my undergraduate and medical school training at Queen's University at Kingston. After 7 years in rural family medicine, I returned to training as a cardiologist and cardiac electrophysiologist at Dartmouth College and McMaster University. Upon completion of my training, I began work here at the Libin Cardiovascular Institute in June, 2008. In 2016, I expanded my interest and training in health policy with an MSc. in health economics from the London School of Economics.
Publications
Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV. Impact of programming strategies aimed at reducing non-essential implantable cardioverter defibrillator therapies on mortality: a systematic review and metaanalysis. Circ.Arrhythm Electrophysiol 2014;7(1):164-170.
Kuriachan V, Sumner G, Mitchell LB. Sudden cardiac death: a review. Curr Prob Cardiol 2014 (40): 133-200.
Thiruganasambandamoorthy V, Kwong K, Stiell I, Swampillai J, Toarta C, Sumner GL, Kuriachan VP, Mukkaram M, Taljaard M, Hazra S, Wells GA, Sheldon RS. Short-term risk of arrhythmias among emergency department syncope patients with non-sinus rhythm. Int J Cardiol 2015; 189 (1)
Hsen Tan, V, Duff H, Gerull B, Sumner GL. Early repolarization syndrome: a case report focusing on dynamic ECG changes prior to ventricular arrhythmias and genetic analysis. Heart Rhythm Case Reports 2015; 15(4).
Rizkallah J, Sumner GL, Sheldon RS. Central vascular catheter fracture during pacemaker lead extraction. Heart Rhythm Case Reports 2015; (10).
Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Verma A, Philippon F, Kalfon E, Eikelboom J, Sandhu RK, Nery PB, Lellouche N, Connolly SJ, Sapp J, and Essebag V for the BRUISE CONTROL-2 Investigators. Continued vs. interrupted direct oral anticoagulants at the time of device surgery in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2). Eur Heart J 2018; (1):1-8.